(Total Views: 508)
Posted On: 10/02/2024 2:19:14 PM
Post# of 148870
FDA Statement,...second to last paragraph..
"If Cytodyn plans further studies of Leronlimab to determine whether the Drug can provide Clinical Benefit tp individuals with COVID-19...the FDA will continue to provide advice to the company on their development program.
Checking in on our Website under the heading of Pipeline; We see the abc's on direction
(a) We are in phase 2 on Long Covid.
(b) We are in phase 2 on Chronic Inflammation,...as it might pertain to "Cytokine Storm."
(c) We are receiving the "Advice" from the FDA...as the lines of communication are mended and Open.
"If Cytodyn plans further studies of Leronlimab to determine whether the Drug can provide Clinical Benefit tp individuals with COVID-19...the FDA will continue to provide advice to the company on their development program.
Checking in on our Website under the heading of Pipeline; We see the abc's on direction
(a) We are in phase 2 on Long Covid.
(b) We are in phase 2 on Chronic Inflammation,...as it might pertain to "Cytokine Storm."
(c) We are receiving the "Advice" from the FDA...as the lines of communication are mended and Open.
(8)
(0)Scroll down for more posts ▼
